{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T10:16:16Z","timestamp":1773483376740,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:00:00Z","timestamp":1727827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:00:00Z","timestamp":1727827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10528-024-10934-y","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T01:01:39Z","timestamp":1727830899000},"page":"4331-4341","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Chemical Complementarity of Blood-Sourced, Breast Cancer-Related TCR CDR3s and the CMV UL29 and IE1 Antigens is Associated with Worse Overall Survival"],"prefix":"10.1007","volume":"63","author":[{"given":"Pooja","family":"Neerumalla","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael. T.","family":"Aboujaoude","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tabitha R.","family":"Hudock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna J.","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan H.","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Chobrutskiy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris I.","family":"Chobrutskiy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Blanck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,2]]},"reference":[{"issue":"4","key":"10934_CR1","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/CMR.0000000000000899","volume":"33","author":"DRL Agnila","year":"2023","unstructured":"Agnila DRL, Huda TI, Eakins RA, Patel DN, Hsiang M, Chobrutskiy A, Chobrutskiy BI, Blanck G (2023) Chemical features of melanoma tumor resident TRG CDR3s associated with better survival probabilities. Melanoma Res 33(4):275\u2013282. https:\/\/doi.org\/10.1097\/CMR.0000000000000899","journal-title":"Melanoma Res"},{"issue":"7","key":"10934_CR2","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41423-019-0328-8","volume":"17","author":"JF Arturo","year":"2020","unstructured":"Arturo JF, Chobrutskiy BI, Yeagley M, Patel DN, Falasiri S, Patel JS, Blanck G (2020) Electrostatic complementarity of B-cell receptor CDR3s and TP53-mutant amino acids in breast cancer is associated with increased disease-free survival rates. Cell Mol Immunol 17(7):776\u2013778. https:\/\/doi.org\/10.1038\/s41423-019-0328-8","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"10934_CR3","doi-asserted-by":"publisher","first-page":"e13248","DOI":"10.1111\/sji.13248","volume":"97","author":"L Bergantini","year":"2023","unstructured":"Bergantini L, d\u2019Alessandro M, Cavallaro D, Pordon E, Cassai L, Gangi S, Meloni F, Montagnani F, Paladini P, Refini RM, Luzzi L, Fossi A, Bargagli E, Bennett D (2023) Immune checkpoint analysis of T-cell responses to pp65 and IE-1 antigens in end-stage lung diseases. Scand J Immunol 97(4):e13248. https:\/\/doi.org\/10.1111\/sji.13248","journal-title":"Scand J Immunol"},{"key":"10934_CR4","doi-asserted-by":"publisher","DOI":"10.14800\/ccm.678","author":"RK Bishop","year":"2015","unstructured":"Bishop RK, Valle Oseguera CA, Spencer JV (2015) Human cytomegalovirus interleukin-10 promotes proliferation and migration of MCF-7 breast cancer cells. Cancer Cell Microenviron. https:\/\/doi.org\/10.14800\/ccm.678","journal-title":"Cancer Cell Microenviron"},{"issue":"1","key":"10934_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CMR.16.1.1-17.2003","volume":"16","author":"EM Burd","year":"2003","unstructured":"Burd EM (2003) Human papillomavirus and cervical cancer. Clin Microbiol Rev 16(1):1\u201317. https:\/\/doi.org\/10.1128\/CMR.16.1.1-17.2003","journal-title":"Clin Microbiol Rev"},{"issue":"7216","key":"10934_CR6","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/nature07385","volume":"455","author":"Cancer Genome Atlas Research N","year":"2008","unstructured":"Cancer Genome Atlas Research N (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455(7216):1061\u20131068. https:\/\/doi.org\/10.1038\/nature07385","journal-title":"Nature"},{"issue":"3","key":"10934_CR7","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s11060-018-03001-1","volume":"140","author":"BI Chobrutskiy","year":"2018","unstructured":"Chobrutskiy BI, Zaman S, Tong WL, Diviney A, Blanck G (2018) Recovery of T-cell receptor V(D)J recombination reads from lower grade glioma exome files correlates with reduced survival and advanced cancer grade. J Neurooncol 140(3):697\u2013704. https:\/\/doi.org\/10.1007\/s11060-018-03001-1","journal-title":"J Neurooncol"},{"key":"10934_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.molimm.2021.02.026","volume":"135","author":"BI Chobrutskiy","year":"2021","unstructured":"Chobrutskiy BI, Chobrutskiy A, Zaman S, Yeagley M, Huda TI, Blanck G (2021) High-throughput, sliding-window algorithm for assessing chemical complementarity between immune receptor CDR3 domains and cancer mutant peptides: TRG-PIK3CA interactions and breast cancer. Mol Immunol 135:247\u2013253. https:\/\/doi.org\/10.1016\/j.molimm.2021.02.026","journal-title":"Mol Immunol"},{"key":"10934_CR9","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/978-1-0716-2712-9_13","volume":"2574","author":"W Chronister","year":"2022","unstructured":"Chronister W, Sette A, Peters B (2022) Epitope-specific T cell receptor data and tools in the immune epitope database. Methods Mol Biol 2574:267\u2013280. https:\/\/doi.org\/10.1007\/978-1-0716-2712-9_13","journal-title":"Methods Mol Biol"},{"issue":"11","key":"10934_CR10","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1038\/sj.bjc.6605675","volume":"102","author":"B Cox","year":"2010","unstructured":"Cox B, Richardson A, Graham P, Gislefoss RE, Jellum E, Rollag H (2010) Breast cancer, cytomegalovirus and Epstein-Barr virus: a nested case-control study. Br J Cancer 102(11):1665\u20131669. https:\/\/doi.org\/10.1038\/sj.bjc.6605675","journal-title":"Br J Cancer"},{"issue":"2","key":"10934_CR11","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41435-023-00201-2","volume":"24","author":"MJ Diaz","year":"2023","unstructured":"Diaz MJ, Kacsoh DB, Patel DN, Yeagley M, Hsiang M, Blanck G (2023) Tumor resident, TRA anti-viral CDR3 chemical sequence motifs are associated with a better breast cancer outcome. Genes Immun 24(2):92\u201398. https:\/\/doi.org\/10.1038\/s41435-023-00201-2","journal-title":"Genes Immun"},{"key":"10934_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4137\/CIN.S35784","volume":"15","author":"TR Gill","year":"2016","unstructured":"Gill TR, Samy MD, Butler SN, Mauro JA, Sexton WJ, Blanck G (2016) Detection of productively rearranged TcR-alpha V-J sequences in TCGA exome files: implications for tumor immunoscoring and recovery of antitumor T-cells. Cancer Inform 15:23\u201328. https:\/\/doi.org\/10.4137\/CIN.S35784","journal-title":"Cancer Inform"},{"issue":"4","key":"10934_CR13","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1159\/000525277","volume":"65","author":"I Gupta","year":"2022","unstructured":"Gupta I, Al-Sarraf R, Farghaly H, Vranic S, Sultan AA, Al-Thawadi H, Al Moustafa AE, Al-Farsi HF (2022) Incidence of HPVs, EBV, and MMTV-like virus in breast cancer in qatar. Intervirology 65(4):188\u2013194. https:\/\/doi.org\/10.1159\/000525277","journal-title":"Intervirology"},{"issue":"6","key":"10934_CR14","doi-asserted-by":"publisher","first-page":"693","DOI":"10.4149\/neo_2012_088","volume":"59","author":"XY He","year":"2012","unstructured":"He XY, Yang WM, Tang WT, Ma R, Sun YP, Wang P, Yao XS (2012) TRAV gene expression in PBMCs and TILs in patients with breast cancer analyzed by a DNA melting curve (FQ-PCR) technique for TCR alpha chain CDR3 spectratyping. Neoplasma 59(6):693\u2013699. https:\/\/doi.org\/10.4149\/neo_2012_088","journal-title":"Neoplasma"},{"issue":"1","key":"10934_CR15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3233\/CBM-230047","volume":"38","author":"TR Hudock","year":"2023","unstructured":"Hudock TR, Barker VR, Manley BJ, Chobrutskiy A, Chobrutskiy BI, Diaz MJ, Song JJ, Blanck G (2023) TRB CDR3-cancer testis antigen chemical complementarity scoring for identifying productive immune responses in renal cell carcinoma. Cancer Biomark 38(1):103\u2013110. https:\/\/doi.org\/10.3233\/CBM-230047","journal-title":"Cancer Biomark"},{"key":"10934_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-05059-5","author":"DB Kacsoh","year":"2023","unstructured":"Kacsoh DB, Diaz MJ, Gozlan EC, Sahoo A, Song JJ, Yeagley M, Chobrutskiy A, Chobrutskiy BI, Blanck G (2023) Blood-based T cell receptor anti-viral CDR3s are associated with worse overall survival for neuroblastoma. J Cancer Res Clin Oncol. https:\/\/doi.org\/10.1007\/s00432-023-05059-5","journal-title":"J Cancer Res Clin Oncol"},{"key":"10934_CR17","doi-asserted-by":"publisher","first-page":"117693512311772","DOI":"10.1177\/11769351231177269","volume":"22","author":"N Pakasticali","year":"2023","unstructured":"Pakasticali N, Chobrutskiy A, Patel DN, Hsiang M, Zaman S, Cios KJ, Blanck G, Chobrutskiy BI (2023) Chemical complementarity of breast cancer resident, T-cell receptor CDR3 domains and the cancer antigen, ARMC3, is associated with higher levels of survival and granzyme expression. Cancer Inform. 22:11769351231177268. https:\/\/doi.org\/10.1177\/11769351231177269","journal-title":"Cancer Inform."},{"issue":"2","key":"10934_CR18","doi-asserted-by":"publisher","first-page":"e0118989","DOI":"10.1371\/journal.pone.0118989","volume":"10","author":"AK Richardson","year":"2015","unstructured":"Richardson AK, Currie MJ, Robinson BA, Morrin H, Phung Y, Pearson JF, Anderson TP, Potter JD, Walker LC (2015) Cytomegalovirus and Epstein-Barr virus in breast cancer. PLoS ONE 10(2):e0118989. https:\/\/doi.org\/10.1371\/journal.pone.0118989","journal-title":"PLoS ONE"},{"issue":"12","key":"10934_CR19","doi-asserted-by":"publisher","first-page":"609","DOI":"10.5732\/cjc.014.10190","volume":"33","author":"M Rowe","year":"2014","unstructured":"Rowe M, Fitzsimmons L, Bell AI (2014) Epstein-Barr virus and burkitt lymphoma. Chin J Cancer 33(12):609\u2013619. https:\/\/doi.org\/10.5732\/cjc.014.10190","journal-title":"Chin J Cancer"},{"issue":"3","key":"10934_CR20","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/21645515.2016.1246095","volume":"13","author":"WL Tong","year":"2017","unstructured":"Tong WL, Tu YN, Samy MD, Sexton WJ, Blanck G (2017) Identification of immunoglobulin V(D)J recombinations in solid tumor specimen exome files: evidence for high level B-cell infiltrates in breast cancer. Hum Vaccin Immunother 13(3):501\u2013506. https:\/\/doi.org\/10.1080\/21645515.2016.1246095","journal-title":"Hum Vaccin Immunother"},{"key":"10934_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11175221","author":"T Yang","year":"2022","unstructured":"Yang T, Liu D, Fang S, Ma W, Wang Y (2022) Cytomegalovirus and glioblastoma: a review of the biological associations and therapeutic strategies. J Clin Med. https:\/\/doi.org\/10.3390\/jcm11175221","journal-title":"J Clin Med"},{"key":"10934_CR22","doi-asserted-by":"publisher","first-page":"1202138","DOI":"10.3389\/fcimb.2023.1202138","volume":"13","author":"C Yu","year":"2023","unstructured":"Yu C, He S, Zhu W, Ru P, Ge X, Govindasamy K (2023) Human cytomegalovirus in cancer: the mechanism of HCMV-induced carcinogenesis and its therapeutic potential. Front Cell Infect Microbiol 13:1202138. https:\/\/doi.org\/10.3389\/fcimb.2023.1202138","journal-title":"Front Cell Infect Microbiol"},{"key":"10934_CR23","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2019.0156","author":"S Zaman","year":"2020","unstructured":"Zaman S, Chobrutskiy BI, Patel JS, Diviney A, Tu YN, Tong WL, Gill T, Blanck G (2020) Antiviral T cell receptor complementarity determining region-3 sequences are associated with a worse cancer outcome: a pancancer analysis. Viral Immunol. https:\/\/doi.org\/10.1089\/vim.2019.0156","journal-title":"Viral Immunol"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-024-10934-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-024-10934-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-024-10934-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T07:13:31Z","timestamp":1758957211000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-024-10934-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,2]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10934"],"URL":"https:\/\/doi.org\/10.1007\/s10528-024-10934-y","relation":{},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,2]]},"assertion":[{"value":"18 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethics approvals from dbGaP are indicated by specific approval numbers, allowing access to the WXS files, indicated in Methods.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}